PCSK9 Inhibitors

Dr. Peter Attia on Mastering Longevity – Insights on Cancer Prevention, Heart Disease, and Aging

FoundMyFitness

A class of drugs developed from Helen Hobbs' discovery that degrade LDL receptors, effectively lowering ApoB and LDL cholesterol with virtually no side effects, but are currently expensive.

334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more

Peter Attia MD